Reprogramming Cancer Cells in Endocrine-Related Tumors: Open Issues

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|9|1146-1151

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.9, 2014-03, pp. : 1146-1151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Systemic Approach to Cancer Treatment: Tumor Cell Reprogramming Focused on Endocrine-Related Cancers

By  

Current Medicinal Chemistry, Vol. 21, Iss. 9, 2014-03 ,pp. : 1072-1081

Bentham Science Publishers

Access to resources Recommend Favorite

A Systemic Approach to Cancer Treatment: Tumor Cell Reprogramming Focused on Endocrine-Related Cancers

By Biava P.M.   Nicolini A.   Ferrari P.   Carpi A.   Sell S.  

Current Medicinal Chemistry, Vol. 21, Iss. 9, 2014-03 ,pp. : 1072-1081

Bentham Science Publishers

Access to resources Recommend Favorite

“Metabolic Reprogramming” in Ovarian Cancer Cells Resistant to Cisplatin

By  

Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-02 ,pp. : 226-235

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Endocrine Related Cancer: From Stem Cells to New Drug Targets)

By  

Current Medicinal Chemistry, Vol. 21, Iss. 9, 2014-03 ,pp. : 1071-1071

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Reprogramming of Normal and Cancer Stem Cells (Guest Editor: Pier Mario Biava)]

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 2, 2011-02 ,pp. : 145-145

Bentham Science Publishers

Access to resources Recommend Favorite